Company
Every investor coverage indicates participated in a round Primal Organix raised.
Companies Primal Organix acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Frank Giampieri | Chief Science Officer | Wholesale Investor |
| Mark Garbelotto | CEO | Wholesale Investor |
Stories naming Primal Organix. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Wholesale Investor profiles Primal Organix, a terpene supplement maker, listing its sales, margins and leadership as it seeks A$5 million from investors to expand its product range and enter new markets.